Eisai Co Ltd (TSE:4523)
円 6847 83 (1.23%) Market Cap: 1.96 Til Enterprise Value: 1.84 Til PE Ratio: 40.66 PB Ratio: 2.40 GF Score: 60/100

Full Year 2020 Eisai Co Ltd Earnings Call Transcript

May 13, 2020 / 07:30AM GMT
Release Date Price: 円7408 (-1.71%)
Unidentified Company Representative

It's now time. We would like to begin financial results presentation on fiscal 2019 results. Because of COVID-19 infection situation, today we are live distributing -- streamcasting the financial results presentation.

I would now like to introduce the presenter today, Representative Director and CEO, Mr. Haruo Naito. Without further ado, I would like to -- I'll give the microphone to Mr. Naito.

Haruo Naito
Eisai Co., Ltd. - CEO, Representative Corporate Officer & Director

Naito speaking. Now I would like to give you a presentation on the financial results for fiscal year 2019. Please look at the slide.

Given the current circumstances surrounding COVID-19 pandemic, we are a pharmaceutical company. Therefore, we believe that there are many roles that we should play, out of which, I think, what is most important is described on this page, which is stable supply of our products. Needless to say, each pharmaceutical product is leading to quality of life or lives of patients. Therefore, these are all life-related

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot